Concepedia

Adoptive Transfer of Autologous Invariant Natural Killer T Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial

Yao Gao, Jia Guo, Xuli Bao, Fang Xiong, Yanpin Ma, Bingqin Tan, Lele Yu, Yong Zhao, Jun Lu

The Oncologist · 2021 · 37 citations · 30 references

DOIFull text

Open access

Abstract

Autologous iNKT cell treatment is safe and well-tolerated. Expanded iNKT cells produce Th1-like responses with possible antitumor activity. The antitumor effects of iNKT cell infusion in patients with advanced HCC merit further investigation.

References

30

Transection of the oesophagus for bleeding oesophageal varices

R. N. H. Pugh, I M Murray-Lyon, J L Dawson et al. · British journal of surgery · 1973 · 7.9K citations

, , +15

CD1d-Restricted and TCR-Mediated Activation of V <sub>α</sub> 14 NKT Cells by Glycosylceramides

Tetsu Kawano, Junqing Cui, Yasuhiko Koezuka et al. · Science · 1997 · 2.4K citations

, , +17

An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.

Olivier Lantz, Albert Bendelac · The Journal of Experimental Medicine · 1994 · 1K citations · Full text

, , +13

Central memory self/tumor-reactive CD8 <sup>+</sup> T cells confer superior antitumor immunity compared with effector memory T cells

Christopher A. Klebanoff, Luca Gattinoni, Parizad Torabi‐Parizi et al. · Proceedings of the National Academy of Sciences · 2005 · 950 citations · Full text

Cutting Edge: Cross-Talk Between Cells of the Innate Immune System: NKT Cells Rapidly Activate NK Cells

Claude Carnaud, Daniel Lee, Olivier Donnars et al. · The Journal of Immunology · 1999 · 851 citations · Full text

, , +16